241 related articles for article (PubMed ID: 22848638)
21. An ophthalmic solution of a peroxisome proliferator-activated receptor gamma agonist prevents corneal inflammation in a rat alkali burn model.
Uchiyama M; Shimizu A; Masuda Y; Nagasaka S; Fukuda Y; Takahashi H
Mol Vis; 2013; 19():2135-50. PubMed ID: 24194635
[TBL] [Abstract][Full Text] [Related]
22. Rapamycin inhibits corneal inflammatory response and neovascularization in a mouse model of corneal alkali burn.
Li J; Han J; Shi Y; Liu M
Exp Eye Res; 2023 Aug; 233():109539. PubMed ID: 37315833
[TBL] [Abstract][Full Text] [Related]
23. Enhanced experimental corneal neovascularization along with aberrant angiogenic factor expression in the absence of IL-1 receptor antagonist.
Lu P; Li L; Liu G; Zhang X; Mukaida N
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4761-8. PubMed ID: 19458323
[TBL] [Abstract][Full Text] [Related]
24.
Estrella-Mendoza MF; Jiménez-Gómez F; López-Ornelas A; Pérez-Gutiérrez RM; Flores-Estrada J
Nutrients; 2019 May; 11(5):. PubMed ID: 31137826
[TBL] [Abstract][Full Text] [Related]
25. Chemical injury-induced corneal opacity and neovascularization reduced by rapamycin via TGF-β1/ERK pathways regulation.
Shin YJ; Hyon JY; Choi WS; Yi K; Chung ES; Chung TY; Wee WR
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4452-8. PubMed ID: 23716625
[TBL] [Abstract][Full Text] [Related]
26. Dexamethasone and MicroRNA-204 Inhibit Corneal Neovascularization.
Zhang X; Wang G; Wang Q; Jiang R
Mil Med; 2024 Jan; 189(1-2):374-378. PubMed ID: 36043264
[TBL] [Abstract][Full Text] [Related]
27. Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury.
Yamada J; Dana MR; Sotozono C; Kinoshita S
Exp Eye Res; 2003 Feb; 76(2):161-7. PubMed ID: 12565803
[TBL] [Abstract][Full Text] [Related]
28. NK1 receptor antagonists as a new treatment for corneal neovascularization.
Bignami F; Giacomini C; Lorusso A; Aramini A; Rama P; Ferrari G
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6783-94. PubMed ID: 25228541
[TBL] [Abstract][Full Text] [Related]
29. Alkali burn to the eye: protection using TNF-α inhibition.
Cade F; Paschalis EI; Regatieri CV; Vavvas DG; Dana R; Dohlman CH
Cornea; 2014 Apr; 33(4):382-9. PubMed ID: 24488127
[TBL] [Abstract][Full Text] [Related]
30. Bovine lactoferrin promotes corneal wound healing and suppresses IL-1 expression in alkali wounded mouse cornea.
Pattamatta U; Willcox M; Stapleton F; Garrett Q
Curr Eye Res; 2013 Nov; 38(11):1110-7. PubMed ID: 23898919
[TBL] [Abstract][Full Text] [Related]
31. Suppression of alkali burn-induced corneal neovascularization by dendritic cell vaccination targeting VEGF receptor 2.
Mochimaru H; Usui T; Yaguchi T; Nagahama Y; Hasegawa G; Usui Y; Shimmura S; Tsubota K; Amano S; Kawakami Y; Ishida S
Invest Ophthalmol Vis Sci; 2008 May; 49(5):2172-7. PubMed ID: 18263815
[TBL] [Abstract][Full Text] [Related]
32. Effects of topical chondrocyte-derived extracellular matrix treatment on corneal wound healing, following an alkali burn injury.
Yang JW; Lee SM; Oh KH; Park SG; Choi IW; Seo SK
Mol Med Rep; 2015 Jan; 11(1):461-7. PubMed ID: 25333196
[TBL] [Abstract][Full Text] [Related]
33. Comparison of genome-wide gene expression in suture- and alkali burn-induced murine corneal neovascularization.
Jia C; Zhu W; Ren S; Xi H; Li S; Wang Y
Mol Vis; 2011; 17():2386-99. PubMed ID: 21921991
[TBL] [Abstract][Full Text] [Related]
34. The long-term effect of tacrolimus on alkali burn-induced corneal neovascularization and inflammation surpasses that of anti-vascular endothelial growth factor.
Chen L; Zhong J; Li S; Li W; Wang B; Deng Y; Yuan J
Drug Des Devel Ther; 2018; 12():2959-2969. PubMed ID: 30254425
[TBL] [Abstract][Full Text] [Related]
35. Alkali burn versus suture-induced corneal neovascularization in C57BL/6 mice: an overview of two common animal models of corneal neovascularization.
Giacomini C; Ferrari G; Bignami F; Rama P
Exp Eye Res; 2014 Apr; 121():1-4. PubMed ID: 24560796
[TBL] [Abstract][Full Text] [Related]
36. Protective Effect of TLR4 Ablation against Corneal Neovascularization following Chemical Burn in a Mouse Model.
Friedman M; Azrad-Lebovitz T; Morzaev D; Zahavi A; Marianayagam NJ; Nicholson JD; Brookman M; Michowiz S; Hochhauser E; Goldenberg-Cohen N
Curr Eye Res; 2019 May; 44(5):505-513. PubMed ID: 30595046
[TBL] [Abstract][Full Text] [Related]
37. Features of corneal neovascularization and lymphangiogenesis induced by different etiological factors in mice.
Shi W; Ming C; Liu J; Wang T; Gao H
Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):55-67. PubMed ID: 20640436
[TBL] [Abstract][Full Text] [Related]
38. LRG1 facilitates corneal fibrotic response by inducing neutrophil chemotaxis via Stat3 signaling in alkali-burned mouse corneas.
Yu B; Yang L; Song S; Li W; Wang H; Cheng J
Am J Physiol Cell Physiol; 2021 Sep; 321(3):C415-C428. PubMed ID: 34260299
[TBL] [Abstract][Full Text] [Related]
39. Forkhead Domain Inhibitor-6 Suppresses Corneal Neovascularization and Subsequent Fibrosis After Alkali Burn in Rats.
Lan C; Liu G; Huang L; Wang X; Tan J; Wang Y; Fan N; Zhu Y; Yu M; Liu X
Invest Ophthalmol Vis Sci; 2022 Apr; 63(4):14. PubMed ID: 35446346
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic effects of three human-derived materials in a mouse corneal alkali burn model.
Han KE; Park MH; Kong KH; Choi E; Choi KR; Jun RM
Cutan Ocul Toxicol; 2019 Dec; 38(4):315-321. PubMed ID: 30741024
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
